Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Experience design of physical spaces: a human-centred approach

    White Papers and Resources | May 25, 2016 | Blue Latitude Health

    Anna Tamasi from Blue Latitude Health highlights the key considerations and best practices for spatial design from a user experience design perspective.

    Focus on immunotherapies: special magazine from Blue Latitude Health

    White Papers and Resources | May 20, 2016 | Blue Latitude Health

    Blue Latitude Health have worked with four of the eight immunotherapies currently approved by the FDA, so we've pooled our expertise across the different capabilities to give you a clear...

    What’s the best use of video in digital pharma marketing?

    White Papers and Resources | May 18, 2016 | Anthill Agency

    Video is increasingly popular in marketing communications. It can work brilliantly but not everywhere and not all the time. So if you’re considering using video, here’s quick strategy for maximizing...

    Living with Crohn’s Report

    White Papers and Resources | May 17, 2016 | Inizio

    Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?

    Infographic: Research Partnership

    White Papers and Resources | May 17, 2016 | Inizio

    Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.

    AAD conference 2016

    White Papers and Resources | May 17, 2016 | Inizio

    Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients

    Video: Global Biosimilars Market

    White Papers and Resources | May 16, 2016 | Inizio

    Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch

    Case study: Understanding Patient Willingness to Pay in Emerging Markets

    White Papers and Resources | May 16, 2016 | Inizio

    Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket.Find out...

    From promise to practice: immuno-oncology in action Part 3 – Emerging Markets

    White Papers and Resources | May 16, 2016 | Inizio

    Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.

    Lucid reach the shortlist for Communiqué 2016 in SIX categories

    Press Releases | May 13, 2016 | Lucid Group Communications Limited

    Lucid Group are celebrating the news that for the first time they have been shortlisted in six different categories at this year’s Communiqué awards.  The categories are:Excellence in Communications of...